Odvina, Clarita V <br/><br/>
Severely suppressed bone turnover: a potential complication of alendronate therapy.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Mar 2005 
 - 1294-301 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2004-0952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alendronate--adverse effects<br/>Biopsy<br/>Bone Density--drug effects<br/>Bone Resorption--chemically induced<br/>Female<br/>Fracture Healing<br/>Fractures, Bone--etiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteoclasts--drug effects<br/>Osteoporosis--drug therapy<br/>Severity of Illness Index